Anxiety-depressive disorders among irritable bowel syndrome patients in Guilan, Iran.

BMC Research Notes
Mohamad-Jafar ModabberniaSiamak Bidel

Abstract

Psychiatric disorders are common in irritable bowel syndrome (IBS) patients. The prevalence of psychiatric disorders in IBS patients varies in different cultures. We conducted this study to determine the prevalence of psychiatric disorders In a cross-sectional study, 256 IBS patients were selected (using the criteria of Rome III) and evaluated for psychiatric disorders. In the first phase, subjects were screened using the General Health Questionnaire 28 (GHQ28). In the second phase, those who had scores ≥ 23 were assessed through semi-structured psychiatric interviews. Thirty out of 256 subjects had no significant psychiatric symptoms after performing GHQ28. In further psychiatric evaluation of the remaining subjects (226) who suffered from some degree of a psychiatric problem, 36 were diagnosed without Anxiety/Depressive disorder. Thus 66 subjects (25.8%) were known as a group without any significant psychiatric problem. A total of 190 subjects (74.2%) with anxiety-depressive problems were diagnosed; 89 were suffering from pure anxiety disorders, 41 were suffering from depressive disorders and 60 had co-morbid anxiety-depressive disorders. When comparing anxiety-depressive patients (n = 190) with normal subjects (n = 66), gend...Continue Reading

References

Jan 1, 1990·Behaviour Research and Therapy·E B BlanchardD H Barlow
Nov 1, 1996·Digestive Diseases and Sciences·W E WhiteheadE Taub
Aug 24, 1999·Gut·D A DrossmanW E Whitehead
Jun 12, 2001·Journal of Psychosomatic Research·E B BlanchardS M Turner
Mar 19, 2003·Alimentary Pharmacology & Therapeutics·A P S HunginF Mearin
Jul 16, 2003·Gastroenterology Clinics of North America·Adriane I Budavari, Kevin W Olden
Jan 2, 2004·The British Journal of Psychiatry : the Journal of Mental Science·A A NoorbalaK Mohammad
Apr 20, 2004·Journal of Psychosomatic Research·Per FinkMarie-Louise Oxhøj
Jul 17, 2004·Digestion·Magnus SimrénPeter J Whorwell
May 9, 2006·Gastroenterology·Rona L LevyFrancis Creed
May 9, 2006·Gastroenterology·George F LongstrethRobin C Spiller
Jul 18, 2006·Alimentary Pharmacology & Therapeutics·J TackG Fisher
May 10, 2007·Gut·R SpillerUNKNOWN Clinical Services Committee of The British Society of Gastroenterology
Sep 20, 2007·International Journal of Clinical Practice·C U PaeA A Patkar
Jan 8, 2008·The American Journal of Gastroenterology·Denesh K ChitkaraWilliam E Whitehead
Jul 8, 2008·Clinical Practice and Epidemiology in Mental Health : CP & EMH·Mohamad Jafar ModaberniaAmir Hossein Modabbernia
Nov 4, 2008·Digestive Diseases and Sciences·Kevin C CainMargaret M Heitkemper
Jan 23, 2009·The Cochrane Database of Systematic Reviews·Ingeborg L ZijdenbosA Otto Quartero
Apr 7, 2010·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·P JerndalM Simrén
Aug 25, 2010·Journal of Clinical Gastroenterology·Annemieke Y ThijssenAd A M Masclee

❮ Previous
Next ❯

Citations

Dec 19, 2013·Behavioral and Brain Functions : BBF·Jia LuoFeng Jin
Oct 19, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Yixuan LiuLiping Duan
Feb 14, 2016·Journal of Evidence-based Complementary & Alternative Medicine·Maryam Mosaffa-JahromiKamran Bagheri Lankarani
Mar 9, 2017·Arquivos De Gastroenterologia·Nadieh BaniasadiZohreh Oghabian
Dec 30, 2017·Indian Journal of Psychological Medicine·Arko BanerjeeGopal Krishna Dhali
Jun 4, 2019·Alimentary Pharmacology & Therapeutics·Mohammad ZamaniVahid Zamani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.